Raia Drogasil X Onofre

Abstract

RD, responsible for the purchase, was formed in 2011 from the merger between Droga Raia and Drogasil, which combine 193 years of history in Brazilian pharmaceutical retail. CVS had purchased Drogaria Onofre in 2013 for approximately US$187 million. The process began in February 2019, when Raia Drogasil (RD) announced the acquisition of Drogaria Onofre, until then under the control of CVS. The acquisition allows the chain to increase its scale in physical retail, in addition to accelerating its digital strategy, increasing the density of deliveries in all states where RD operates, and expanding its operations in e-commerce. With the merger, RD announced that all Onofre physical stores will be converted into Droga Raia and Drogasil, both will continue to be multi-channel, focused more on convenience, and only Onofre will be 100% online, focused on competitive pricing and adding value to the brand’s digital strategy. We will analyze the statements published on BM&FOVESPA and on the RD website < https://www.rd.com.br/ > (accessed in April 2020), to point out the impacts on the results of operations due to this merger of institutions, comparing data for 2018, the period prior to the acquisition, and 2019, which was the first year ended after the completion of the merger of the companies.